Home/Izun Pharmaceuticals/Dr Amy Rosenbluh
DA

Dr Amy Rosenbluh

Director of Production & Laboratory Manager

Izun Pharmaceuticals

Izun Pharmaceuticals Pipeline

DrugIndicationPhase
PeriActive™Periodontal disease (gingivitis, periodontitis)Commercial
CURASITE™Chronic wounds, including diabetic foot ulcersCommercial
IZN‑6N4Oral mucositis in cancer patientsPreclinical
GSM Botanical TherapyGenitourinary Syndrome of MenopausePreclinical